Legend Biotech Corp. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, manufacturing, and commercialization of novel therapies for oncology and other indications. The firm develops advanced cell therapies across a diverse array of technology platforms, including autologous and allogeneic chimeric antigen receptor T-cell, gamma-delta T cell and natural killer cell-based immunotherapy. It operates through the following geographical segments: United States of America, China, and Other. The company was founded in 2014 and is headquartered in Somerset, NJ.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
2,609
Frequently Asked Questions
What is Market Cap of Legend Biotech Corp - ADR?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Legend Biotech Corp - ADR market cap is $6.11B.
What is the 52-week high for Legend Biotech Corp - ADR?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Legend Biotech Corp - ADR 52 week high is $52.31 as of September 13, 2025.
What is the 52-week low for Legend Biotech Corp - ADR?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Legend Biotech Corp - ADR 52 week low is $27.34 as of September 13, 2025.
What is Legend Biotech Corp - ADR stock price today?
Legend Biotech Corp - ADR stock price today is $33.11.
What was Legend Biotech Corp - ADR stock price yesterday?
Legend Biotech Corp - ADR stock price yesterday was $33.83.
What is the PE ratio of Legend Biotech Corp - ADR?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Legend Biotech Corp - ADR’s P/E ratio is -18.67.
What is the Price-to-Book ratio of Legend Biotech Corp - ADR?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Legend Biotech Corp - ADR P/B ratio is 5.9013.
What is the 50-day moving average of Legend Biotech Corp - ADR?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Legend Biotech Corp - ADR 50-day moving average is $37.75.
How many employess does Legend Biotech Corp - ADR has?